Congenital cytomegalovirus infection: An overview

Infectious Disorders - Drug Targets

Volumn 11, Issue 5, 2011, Pages 432-436

  Elliott, Sean P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Congenital cytomegalovirus; Deafness; Infection; Neonate; Sensorineural hearing loss

Indexed keywords

GANCICLOVIR; GLYCOPROTEIN B; VALGANCICLOVIR;

ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONGENITAL CYTOMEGALOVIRUS INFECTION; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; PERCEPTION DEAFNESS; SCREENING; SYMPTOM; UNITED STATES; UNSPECIFIED SIDE EFFECT; VACCINATION;

EID: 80054121894     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/187152611797636712     Document Type: Article

References (48)

1. Craig, J.M.; Macauley, J.C.; Weller, T.H.; Wirth, P. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc. Soc. Exp. Biol. Med., 1957, 94 (1), 4-12.
2. Smith, M.G. Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc. Soc. Exp. Biol. Med., 1956, 92 (2), 424-430.
3. Marshall, G.S.; Stout, G.G. Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period. Am. J. Perinatol., 2005, 22 (7), 371-376.
4. Fowler, K.B.; Pass, R.F. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics, 2006, 118 (2), e286-e292.
5. Nassetta, L.; Kimberlin, D.; Whitley, R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J. Antimicrob. Chemother., 2009, 63 (5), 862-867.
6. Paixão, P.; Almeida, S.; Gouveia, P.; Vilarinho, L.; Vaz Osório, R. Prevalence of human cytomegalovirus congenital infection in Portuguese newborns. Euro. Surveill., 2009, 14 (9), 13-15.
7. Dollard, S.C.; Grosse, S.D.; Ross, D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol., 2007, 17 (5), 355-363.
8. Kenneson, A.; Cannon, M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol., 2007, 17 (4), 253-276.
9. Schleiss, M.R. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection. J. Pediatr., 2007, 151 (6), 564-570.
10. Revello, M.G.; Zavattoni, M.; Furione, M.; Fabbri, E.; Gerna, G. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J. Infect. Dis., 2006, 193 (6), 783-787.
11. Gindes, L.; Teperberg-Oikawa, M.; Sherman, D.; Pardo, J.; Rahav, G. Congenital cytomegalovirus infection following primary maternal infection in the third trimester. BJOG., 2008, 115 (7), 830-835.
12. Pass, R.F.; Fowler, K.B.; Boppana, S.B.; Britt, W.J.; Stagno, S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol., 2006, 35 (2), 216-220.
13. Foulon, I.; Naessens, A.; Foulon, W.; Casteels, A.; Gordts, F. Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred. Pediatrics, 2008, 122 (6), e1123-e1127.
14. Stagno, S.; Britt, W. Cytomegalovirus Infections. In Infectious Diseases of the Fetus and Newborn Infant, 6th ed.; Remington, J.R., Klein, J.O., Wilson, C.B., Baker, C.J., Eds.; Elsevier Saunders: Philadelphia, 2006; pp. 739-781.
15. DeVries, J. The ABCs of CMV. Adv. Neonatal Care, 2007, 7 (5), 248-255.
16. McDonagh, S.; Maidji, E.; Chang, H.T.; Pereira, L. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J. Clin. Virol., 2006, 35 (2), 210-215.
17. Hassan, J.; Connell, J. Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. Clin. Exp. Immunol., 2007, 149 (2), 205-210.
18. Pedron, B.; Guerin, V.; Jacquemard, F.; Munier, A.; Daffos, F.; Thulliez, P.; Aujard, Y.; Luton, D.; Sterkers, G. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J. Infect. Dis., 2007, 196 (7), 1033-1043.
19. Gibson, L.; Dooley, S.; Trzmielina, S.; Somasundaran, M.; Fisher, D.; Revello, M.G.; Luzuriaga, K. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J. Infect. Dis., 2007, 195 (12), 1789-1798.
20. Demmler, G.J. Cytomegalovirus. In Textbook of Pediatric Infectious Diseases, 5th ed.; Feigin, R.D., Cherry, J.D., Demmler, G.J., Kaplan, S.L., Eds.; Saunders: Philadelphia, 2004; pp. 1912-1932.
21. Fowler, K.B.; Boppana, S.B. Congenital cytomegalovirus (CMV) infection and hearing deficit. J. Clin. Virol., 2006, 35 (2), 226-231.
22. Foulon, I.; Naessens, A.; Foulon, W.; Casteels, A.; Gordts, F. A 10- year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J. Pediatr., 2008, 153 (1), 84-88.
23. Zhang, X.W.; Li, F.; Yu, X.W.; Shi, X.W.; Shi, J.; Zhang, J.P. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J. Clin. Virol., 2007, 40 (3), 180-185.
24. Boppana, S.B.; Pass, R.F.; Britt, W.J.; Stagno, S.; Alford, C.A. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. J., 1992, 11 (2), 93-99.
25. Pass, R.F. Cytomegalovirus. In: Principles and Practice of Pediatric Infectious Diseases, 3rd ed.; Long, S.S., Pickering, L.K., Prober, C.G., Eds.; Churchill Livingstone: Philadelphia, 2009; pp. 1029-1036.
26. Griffiths, P.D.; Walter, S. Cytomegalovirus. Curr. Opin. Infect. Dis., 2005, 18 (3), 241-245.
27. Frenkel, L.D.; Keys, M.P.; Hefferen, S.J.; Rola-Pleszczynski, M.; Bellanti, J.A. Unusual eye abnormalities associated with congenital cytomegalovirus infection. Pediatrics, 1980, 66 (5), 763-766.
28. Boppana, S.B.; Fowler, K.B.; Pass, R.F.; Rivera, L.B.; Bradford, R.D.; Lakeman, F.D.; Britt, W.J. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J. Pediatr., 2005, 146 (6), 817-823.
29. Picone, O.; Costa, J.M.; Dejean, A.; Ville, Y. Is fetal gender a risk factor for severe congenital cytomegalovirus infection? Prenat. Diagn., 2005, 25 (1), 34-38.
30. Ancora, G.; Lanari, M.; Lazzarotto, T.; Venturi, V.; Tridapalli, E.; Sandri, F.; Menarini, M.; Ferretti, E.; Faldella, G. Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. J. Pediatr., 2007, 150 (2), 157-161.
31. Benoist, G.; Salomon, L.J.; Mohlo, M.; Suarez, B.; Jacquemard, F.; Ville, Y. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet. Gynecol., 2008, 32 (7), 900-905.
32. Guerra, B.; Simonazzi, G.; Puccetti, C.; Lanari, M.; Farina, A.; Lazzarotto, T.; Rizzo, N. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am. J. Obstet. Gynecol., 2008, 198 (4), 380, e1-e7.
33. Odibo, A.; DeFranco, E.; Krings, K.; Hoff, J.; Stout, M. Predicting congenital cytomegalovirus infection: Guerra et al. Am. J. Obstet. Gynecol., 2008, 198 (4), 480-481.
34. Lanari, M.; Lazzarotto, T.; Venturi, V.; Papa, I.; Gabrielli, L.; Guerra, B.; Landini, M.P.; Faldella, G. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics, 2006, 117 (1), e76-e83. Erratum in: Pediatrics, 2006, 117 (4), 1467.
35. Ducroux, A.; Cherid, S.; Benachi, A.; Ville, Y.; Leruez-Ville, M. Evaluation of new commercial real-time PCR quantification assay for prenatal diagnosis of cytomegalovirus congenital infection. J. Clin. Microbiol., 2008, 46 (6), 2078-2080.
36. Goegebuer, T.; Van Meensel, B.; Beuselinck, K.; Cossey, V.; Van Ranst, M.; Hanssens, M.; Lagrou, K. Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples. J. Clin. Microbiol., 2009, 47 (3), 660-665.
37. Naessens, A.; Casteels, A.; Decatte, L.; Foulon, W. A serologic strategy for detecting neonates at risk for congenital cytomegalovirus infection. J. Pediatr., 2005, 146 (2), 194-197.
38. Demmler, G.J. Screening for congenital cytomegalovirus infection: a tapestry of controversies. J. Pediatr., 2005, 146 (2), 162-164.
39. Atkinson, C.; Walter, S.; Sharland, M.; Tookey, P.; Luck, S.; Peckham, C.; Griffiths, P. Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J. Med. Virol., 2009, 81 (8), 1394-1398.
40. Barbi, M.; Binda, S.; Caroppo, S. Diagnosis of congenital CMV infection via dried blood spots. Rev. Med. Virol., 2006, 16 (6), 385-392.
41. Boppana, S.B.; Ross, S.A.; Novak, Z.; Shimamura, M.; Tolan, R.W., Jr.; Palmer, A.L.; Ahmed, A.; Michaels, M.G.; Sánchez, P.J.; Bernstein D.I.; Britt, W.J.; Fowler, K.B.; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Dried blood spot realtime polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA, 2010, 303 (14), 1375-1382.
42. Ross, S.A.; Novak, Z.; Pati, S.; Boppana, S.B. Overview of the diagnosis of cytomegalovirus infection. Infect. Disord. Drug Targets, 2011, 11, 466-474.
43. Kimberlin, D.W.; Lin, C.Y.; Sánchez, P.J.; Demmler, G.J.; Dankner, W.; Shelton, M.; Jacobs, R.F.; Vaudry, W.; Pass, R.F.; Keill, J.M.; Soong, S.J.; Whitley, R.J.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr., 2003, 143 (1), 16-25.
44. Kimberlin, D.W.; Acosta, E.P.; Sánchez, P.J.; Sood, S.; Agrawal, V.; Homans, J.; Jacobs, R.F.; Lang, D.; Romero, J.R.; Griffin, J.; Cloud, G.A.; Lakeman, F.D.; Whitley, R.J.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J. Infect. Dis., 2008, 197 (6), 836-845.
45. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. http://www.casg.uab.edu/ [Accessed 2nd January, 2010].
46. Duff, P. Immunotherapy for congenital cytomegalovirus infection. N. Engl. J. Med., 2005, 353 (13), 1402-1404.
47. Nigro, G.; Adler, S.P.; La Torre, R.; Best, A.M.; Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med., 2005, 353 (13), 1350-1362.
48. Pass, R.F.; Zhang, C.; Evans, A.; Simpson, T.; Andrews, W.; Huang, M.L.; Corey, L.; Hill, J.; Davis, E.; Flanigan, C.; Cloud, G. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med., 2009, 360 (12), 1191-1199.